Perspectives About Time Frames in Stem Cell Research for Multiple Sclerosis: "Time Is Brain"
Type:
Enduring Material
Credit Hours:
1
Session Description:
Perspectives About Time Frames in Stem Cell Research for Multiple Sclerosis: "Time Is Brain"
Shelly Benjaminy, PhD; Cody Lo, BSc; Andrew Schepmyer, MD; Anthony Traboulsee, MD; Judy Illes, CM, PhD
Method of Participation:
Release Date: August 1, 2019
Valid for Credit Through: August 1, 2020
Follow these steps to earn CME/CNE credit:
Statements of Credit are awarded upon successful completion of the post-test with a passing score of >70% and the evaluation. There is no fee to participate in this activity.
Shelly Benjaminy, PhD; Cody Lo, BSc; Andrew Schepmyer, MD; Anthony Traboulsee, MD; Judy Illes, CM, PhD
Method of Participation:
Release Date: August 1, 2019
Valid for Credit Through: August 1, 2020
Follow these steps to earn CME/CNE credit:
- Review the CME/CNE information, including learning objectives and author disclosures.
- Study the educational content.
- Complete the post-test and evaluation.
Statements of Credit are awarded upon successful completion of the post-test with a passing score of >70% and the evaluation. There is no fee to participate in this activity.
Learning Objectives:
Target Audience:
The target audience for this activity is physicians, physician assistants, nursing professionals, and other health care providers involved in the management of patients with multiple sclerosis (MS).
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Delaware Media Group. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit
The CMSC designates this journal-based activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Credit
The CMSC designates this enduring material for 1.0 contact hour (none in the area of pharmacology).
Disclosures:
Francois Bethoux, MD, Editor in Chief of the International Journal of MS Care (IJMSC), has served as physician planner for this activity. He has disclosed relationships with Springer Publishing (royalty); Qr8 (receipt of intellectual property rights/patent holder); Abide Therapeutics, GW Pharma (consulting fee); Biogen (speakers' bureau); and Adamas Pharmaceuticals (contracted research).
Laurie Scudder, DNP, NP, has served as reviewer for this activity. She has disclosed no relevant financial relationships.
Shelly Benjaminy, PhD, has disclosed no relevant financial relationships.
Cody Lo, BSc, has disclosed no relevant financial relationships.
Andrew Schepmyer, MD, has disclosed no relevant financial relationships.
Anthony Traboulsee, MD, has disclosed relationships with Biogen, Teva, Roche, Merck/EMD Serono, Sanofi Genzyme, Chugai (consulting fee); Sanofi Genzyme (speakers' bureau); and Chugai, Roche, Sanofi Genzyme (contracted research [principal investigator]).
Judy Illes, CM, PhD, has disclosed no relevant financial relationships.
The peer reviewer for IJMSC has disclosed no relevant financial relationships.
The staff at IJMSC, CMSC, and Delaware Media Group who are in a position to influence content have disclosed no relevant financial relationships.
Note: Financial relationships for some authors may have changed in the interval between listing these disclosures and publication of the article.
Disclosure of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. CMSC and Delaware Media Group do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of CMSC or Delaware Media Group.
Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health-care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer's product information, and comparing any therapeutic approach with the recommendations of other authorities.
- Demonstrate knowledge of MS patient and clinician perspectives about the time frames associated with stem cell research and development.
- Integrate evidence-informed clinical communication strategies to clarify translational time frames and promote informed hope about stem cell research into his/her own clinical practice.
Target Audience:
The target audience for this activity is physicians, physician assistants, nursing professionals, and other health care providers involved in the management of patients with multiple sclerosis (MS).
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Delaware Media Group. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Physician Credit
The CMSC designates this journal-based activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Credit
The CMSC designates this enduring material for 1.0 contact hour (none in the area of pharmacology).
Disclosures:
Francois Bethoux, MD, Editor in Chief of the International Journal of MS Care (IJMSC), has served as physician planner for this activity. He has disclosed relationships with Springer Publishing (royalty); Qr8 (receipt of intellectual property rights/patent holder); Abide Therapeutics, GW Pharma (consulting fee); Biogen (speakers' bureau); and Adamas Pharmaceuticals (contracted research).
Laurie Scudder, DNP, NP, has served as reviewer for this activity. She has disclosed no relevant financial relationships.
Shelly Benjaminy, PhD, has disclosed no relevant financial relationships.
Cody Lo, BSc, has disclosed no relevant financial relationships.
Andrew Schepmyer, MD, has disclosed no relevant financial relationships.
Anthony Traboulsee, MD, has disclosed relationships with Biogen, Teva, Roche, Merck/EMD Serono, Sanofi Genzyme, Chugai (consulting fee); Sanofi Genzyme (speakers' bureau); and Chugai, Roche, Sanofi Genzyme (contracted research [principal investigator]).
Judy Illes, CM, PhD, has disclosed no relevant financial relationships.
The peer reviewer for IJMSC has disclosed no relevant financial relationships.
The staff at IJMSC, CMSC, and Delaware Media Group who are in a position to influence content have disclosed no relevant financial relationships.
Note: Financial relationships for some authors may have changed in the interval between listing these disclosures and publication of the article.
Disclosure of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. CMSC and Delaware Media Group do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of CMSC or Delaware Media Group.
Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health-care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer's product information, and comparing any therapeutic approach with the recommendations of other authorities.
Credit Types
CME: 1.00
Letter of Completion: 1.00
NCPD: 1.00
